Lee Chan Henry sold $338K of ONC
Lee Chan Henry (SVP, General Counsel) sold 1,044 shares of BeOne Medicines Ltd. (ONC) at $323.69 ($0.34M total) on 2026-07-30.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale: 1,044 shares sold at $323.6900 on 2026-07-30, totaling $337,932.36, with holdings after the transaction reported as 0 shares and no pre-arranged 10b5-1 plan.
Market read
Traders may note the insider fully exited after the sale, but there is no accompanying operational or financial catalyst in the text.
What to watch
Insider sales can be driven by diversification, tax planning, or pre-existing compensation schedules; without additional context, the signal-to-noise is low.
Background
The article is a SEC Form 4 insider transaction disclosure for BeOne Medicines Ltd. (ONC).
Ticker impact
BeOne Medicines (ONC) disclosed an insider open-market sale by SVP General Counsel Lee Chan Henry of 1,044 shares at $323.69.
Likely limited near-term impact; any reaction would be sentiment-driven and should fade unless followed by additional disclosures.
The filing is primary-source and time-stamped, but it does not include new company performance, guidance, or corporate actions. Insider sales are common and the article provides no linkage to material events beyond the transaction details.
Market effects
No sector read-through is provided; this appears company-specific and transaction-specific.
None indicated.
None indicated.
Counterpoint
The absence of a 10b5-1 plan could be interpreted as less “mechanical,” but the filing still lacks any stated reason or linkage to negative fundamentals.
Key entities
- issuerBeOne Medicines Ltd.
Subject of the Form 4 insider transaction disclosure (ticker ONC).
- insiderLee Chan Henry
SVP, General Counsel who sold 1,044 shares in an open-market sale.
